NCT07264348Not yet recruiting
Cardiometabolic and Hormonal Adaptations to 4-Month Zumba Training in Overweight/Obese Women
Effects of a 4-month Intervention on Cardiometabolic, Hormonal, Inflammatory, Liver, Renal, Electrolyte, and Muscle Enzyme Parameters in Pre- and Post-Menopausal Overweight and Obese Women: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
This study aims to evaluate the effects of a 4 month Zumba training program on cardiometabolic, hormonal, inflammatory, hepatic, renal, and functional parameters in overweight and obese women. Participants will be classified according to menopausal status (pre- or post-menopausal) and randomly assigned to an exercise group or a non-exercise control group.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 73 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 15 Apr 2026
- Lead sponsor
- High Institute of Sports and Physical Education of Kef
- Diseases
- Obesity
- NCT number
- NCT07264348
What you commit to
- Study type: Interventional
- Planned participants: 73
- From 1 Dec 2025 to the primary completion date, 15 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hormonal therapy or weight-loss medications
Other illness
- Endocrine diseases or chronic illness
Other
- Recent intense physical training (\<48 hours before baseline)
Who the study is looking for
- Female, aged 18-65 years
- BMI ≥ 25 kg/m²
- Pre-menopausal or post-menopausal (classified clinically)
- Voluntary written informed consent
Age in the registry: 18 years to 65 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.